A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis
Theranostics · 2026
DOI: 10.7150/thno.129569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Dingyu Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Advanced Materials Technology of the Ministry of Education, School of Life Science and Engineering, Southwest Jiaotong University, …. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Liver Cirrhosis, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Advanced Materials Technology of the Ministry of Education, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
- School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
- School of Clinical Medicine, Dali University, Dali 671000, Yunnan, China.
- School of Pharmacy, Dali University, Dali 671000, Yunnan, China.
Zitieren
APA
Wu, D., Duan, L., Tan, D., Hua, X., Liang, A., Huai, R., Qi, S., Shang, Z., Jia, S., Qi, H., Liu, X., Zhao, J., Jiang, Y., Tan, R., & Mao, C. (2026). A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis. Theranostics. https://doi.org/10.7150/thno.129569
Vancouver
Wu D, Duan L, Tan D, Hua X, Liang A, Huai R, et al. A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis. Theranostics. 2026. doi:10.7150/thno.129569
BibTeX
@article{Wu2026,
author = {Wu, Dingyu and Duan, Lei and Tan, Di and Hua, Xinyi and Liang, Anping and Huai, Ruiping and Qi, Shanshan and Shang, Zhixian and Jia, Shijie and Qi, Hui and Liu, Xinrong and Zhao, Jieling and Jiang, Yuhong and Tan, Rui and Mao, Canquan},
title = {A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.129569}
}
EUVIMED